Abstract

BackgroundTranscutaneous tibial nerve stimulation (TTNS) has been used to treat overactive bladder (OAB), however patient experiences and views of this treatment are lacking. The aim of this study was to explore women’s experiences of OAB and TTNS treatment and the perceived factors influencing participation and adherence.MethodsSemi-structured, individual interviews conducted as part of a mixed-methods, randomised, feasibility trial of self-managed versus HCP-led TTNS. Interviews were audio recorded and transcribed verbatim. Reflexive thematic analysis was undertaken using Booth et al. (Neurourol Urodynam. 2017;37:528–41) approach.Results16 women were interviewed, 8 self-managing TTNS at home and 8 receiving TTNS in twice-weekly hospital clinic appointments. Women self-managing OAB considered TTNS easy to administer, flexible and favourably ‘convenient’, especially when the participant was bound by work and other life commitments. In contrast to OAB symptoms ‘dominating life’, self-managing bladder treatment was empowering and fitted around home life demands. Flexibility and control engendered by self-management, facilitated women’s willingness to participate in TTNS. Women attending a hospital clinic for TTNS enjoyed the social aspects but found the routine appointments constrained their lives. Motivation to continue TTNS in the longer term was dependent on perception of benefit.ConclusionsThis study provides novel insights into women’s experiences of self-managing their OAB using TTNS compared to HCP-led management in the clinical setting. It highlights positive experiences self-managing TTNS at home and a willingness to continue in the longer term, facilitated by ease of use and convenience.Trial Registration 1/11/2018: ClinicalTrials.gov Identifier: NCT03727711.

Highlights

  • Transcutaneous tibial nerve stimulation (TTNS) has been used to treat overactive bladder (OAB), patient experiences and views of this treatment are lacking

  • Overactive bladder (OAB) syndrome is defined as urinary urgency, usually accompanied by frequency and/ or nocturia, with or without incontinence [1]

  • Self-management at home offers the potential for TTNS to be a cost-effective alternative to the minimally invasive Percutaneous Tibial Nerve Stimulation (PTNS) which delivers stimulation via single-use needles inserted by a healthcare practitioner [5]

Read more

Summary

Introduction

Transcutaneous tibial nerve stimulation (TTNS) has been used to treat overactive bladder (OAB), patient experiences and views of this treatment are lacking. Transcutaneous tibial nerve stimulation (TTNS) is a non-invasive, neuromodulation treatment for OAB. A systematic review of 10 RCTs and 3 prospective cohort studies involving 629 participants, showed 48–93% significant symptom improvement following a programme of TTNS [4]. TTNS involves application of reusable skin surface electrodes and electrical stimulation of the tibial nerve as a programme of treatment sessions (usually 12) [4]. Self-management at home offers the potential for TTNS to be a cost-effective alternative to the minimally invasive Percutaneous Tibial Nerve Stimulation (PTNS) which delivers stimulation via single-use needles inserted by a healthcare practitioner [5]. TTNS had shorter preparation time, less discomfort level and higher patient satisfaction than PTNS

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call